Phio Pharmaceuticals Corp.
PHIO • NASDAQ • Stock Fundamentals
Phio Pharmaceuticals Corp. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Robert J. Bitterman, with a market cap of $12.5M.
Market Cap$12.5M
Employees9.0
CEORobert J. Bitterman
CountryUnited States of America
Healthcare
Biotechnology
Most Recent EarningsMay 7, 2026 · 1 month 7 days agoQ1 2026
View reportNext EarningsAug 13, 2026 · in 2 monthsQ2 2026
Financials
Based on Q1 2026 filing
Phio Pharmaceuticals Corp. FAQ
Common questions about Phio Pharmaceuticals Corp.
Phio Pharmaceuticals Corp. (PHIO) has a market capitalization of $12.5M and trades on NASDAQ.
Phio Pharmaceuticals Corp. has approximately 9 employees.